{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:44:38Z","timestamp":1792133078736,"version":"4.4.0"},"reference-count":48,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many mitigation processes have been introduced to reduce septic transfusion reactions (STRs) caused by the transfusion of bacterially contaminated PLTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The efficacy of primary culture and pathogen reduction is assessed in this review using data from long\u2010term hemovigilance programs in the US, Canada, UK, France, Switzerland, and Australia. These surveillance programs are passive, with under\u2010reporting of cases and differences in diagnostic criteria and reporting requirements between countries and institutions, but changes in rates over time reflect changes in the incidence of reported STRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Prior to the introduction of these mitigation methods, reported STR rates ranged from 10 to 100 per million PLT units transfused. Reported STR rates were lowered following the introduction of primary culture using aerobic culture of 8\u201320\u2009mL samples of PLT pools and apheresis collections around 24\u2009h after collection, ranging from 2 to 24 per million PLT units. Use of large volume, delayed sampling (LVDS) primary culture of 16\u201320\u2009mL, using both aerobic and anaerobic culture bottles, of pools and apheresis split units performed 36\u201348\u2009h after collection was associated with a further decrease in reported STR rates, ranging from 0.56 to 4 per million PLT units transfused. Pathogen reduction of apheresis and whole\u2010blood derived PLTs using amotosalen\/UVA was associated with a low incidence of reported STR rates, ranging from 0 to 1.1 per million PLT units transfused.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Reported STR rates using LVDS primary culture were lower than rates using other primary culture methods, with even lower rates using the amotosalen\/UVA for pathogen reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70305","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:33:35Z","timestamp":1781796815000},"page":"1846-1859","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the efficacy of large volume delayed sampling primary culture and pathogen reduction in preventing septic reactions from platelet transfusions"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-7855","authenticated-orcid":false,"given":"Michael R.","family":"Jacobs","sequence":"first","affiliation":[{"name":"Department of Pathology Case Western Reserve University and University Hospitals Cleveland Medical Center  Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2025.104086"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020258"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90120-9"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13247"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2212-9"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1325602"},{"key":"e_1_2_14_8_1","unstructured":"FDA.Bacterial detection testing by blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion.2020. Available from:https:\/\/www.fda.gov\/media\/123448\/download"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185359"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.2298\/VSP1112041J"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.187946"},{"key":"e_1_2_14_12_1","first-page":"348","article-title":"Passive haemovigilance of blood components treated with a riboflavin\u2010based pathogen reduction technology","volume":"16","author":"Piotrowski D","year":"2018","journal-title":"Blood Transfus"},{"key":"e_1_2_14_13_1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3324\/haematol.2020.260430","article-title":"Efficacy of UVC\u2010treated, pathogen\u2010reduced platelets versus untreated platelets: a randomized controlled non\u2010inferiority trial","volume":"106","author":"Brixner V","year":"2021","journal-title":"Haematologica"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14085"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05418.x"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41121493.x"},{"key":"e_1_2_14_17_1","volume-title":"The 2024 annual SHOT report","author":"Narayan S","year":"2025"},{"key":"e_1_2_14_18_1","volume-title":"Clinical recognition and investigation of suspected bacterial contamination of platelets","author":"AABB","year":"2014"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01131.x"},{"key":"e_1_2_14_20_1","unstructured":"International Haemovigilance Network.2025. Available from:https:\/\/ihn-org.com\/"},{"key":"e_1_2_14_21_1","unstructured":"CBER\u2010FDA.Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2016. Available from:https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/SafetyAvailability\/ReportaProblem\/TransfusionDonationFatalities\/UCM598243.pdf2017"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/529143"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15780"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-655944"},{"key":"e_1_2_14_25_1","unstructured":"Causascientia.2018. Available from:https:\/\/www.causascientia.org\/math_stat\/ProportionCI.html"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18187"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14308"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.01.001"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.70053"},{"key":"e_1_2_14_30_1","first-page":"6","article-title":"Bacterial contamination and sepsis associated with transfusion: current status in Latin America","volume":"6","author":"M\u2010As G\u2010O","year":"2021","journal-title":"Anna Blood"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18457"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2910.230869"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41070862.x"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.70199"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000330466"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.70253"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14202"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000489900"},{"key":"e_1_2_14_39_1","unstructured":"Swissmedic haemovigilance annual report.2023. Available from:https:\/\/www.swissmedic.ch\/dam\/swissmedic\/en\/dokumente\/marktueberwachung\/haemovigilance\/haemovigilance_jahresbericht_2023.pdf.download.pdf\/Haemovigilance%20Annual%20Report%202023.pdf\/2024"},{"key":"e_1_2_14_40_1","first-page":"350","article-title":"Bacteria in blood for transfusion. A review","volume":"118","author":"Sazama K","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1979.19179160264.x"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33393174448.x"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid3009.240372"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17589"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6823a2"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16776"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16210"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12519"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700839"}],"updated-by":[{"DOI":"10.1111\/trf.70407","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000}}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70305","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70305","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:51:49Z","timestamp":1789167109000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/trf.70305"],"URL":"https:\/\/doi.org\/10.1111\/trf.70305","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"2026-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}